Cervical cancer screening among adult women in China, 2010

Oncologist

Volumn 20, Issue 6, 2015, Pages 627-634

  Wang, Baohua ^a   He, Minfu ^a   Chao, Ann ^b   Engelgau, Michael M ^c   Saraiya, Mona ^d   Wang, Limin ^a   Wang, Linhong ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cervical cancer; China; Epidemiology; Papanicolaou test; Women

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CHINA; EDUCATION; FEMALE; HEALTH INSURANCE; HUMAN; MARRIAGE; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; RURAL AREA; SAMPLING; URBAN AREA; UTERINE CERVIX CANCER; VERY ELDERLY; ADOLESCENT; ATTITUDE TO HEALTH; EARLY CANCER DIAGNOSIS; MASS SCREENING; MIDDLE AGED; PATHOLOGY; SOCIOECONOMICS; UTERINE CERVICAL NEOPLASMS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHINA; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS;

EID: 84932608265     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2014-0303     Document Type: Article

References (33)

1. He J, Chen WQ. 2012 Chinese Cancer Registry Annual Report. Beijing, China. Beijing, People’s Republic of China: Military Medical Science Press, 2012.
2. World Health Organization. National Cancer Control Programmes: Policiesand Managerial Guidelines. 2nd ed.Geneva, Switzerland: World Health Organization, 2002.
3. WorldHealthOrganization(WHO). WHO Guidance Note: Comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women. Geneva, Switzerland: World Health Organization, 2013.
4. Yang G, Hu J, Rao KQ et al. Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr 2005;3:3.
5. Zhou MG, Jiang Y, Huang ZJ et al. Adjustment and representativeness evaluation of national disease surveillance points system [in Chinese]. Dis Surveill 2010;25:239-244.
6. National Center for Chronic and Noncommuni-cable Disease Control and Prevention, Chinese Center for Disease Control and Prevention. Report on Chronic Disease and Risk Factor Surveillance in China 2010 [in Chinese]. Beijing, People’s Republic of China: Military Medical Science Press, 2012.
7. Wang BH, He MF, Wang LM et al. Breast cancer screening among adult women in China, 2010. Prev Chronic Dis 2013;10:130136.
8. Zhao EF, Bao L, Li C et al. Changes in epidemiology and clinical characteristics of cervical cancer over the past 50years [in Chinese]. J First Mil Med Univ 2005;25:605-609.
9. World Health Organization (WHO). United Nations High-Level Meeting on Noncommunicable Disease Prevention and Control. Available at http://www.who.int/nmh/events/un_ncd_summit2011/ en/. Accessed January 6, 2014.
10. International Agency for Research on Cancer (IARC). Cervix Cancer Screening. Vol 10. Lyon, France: IARC Press, 2005.
11. Jin XW, Lipold L, McKenzie M et al. Cervical cancer screening: What’s new and what’s coming? Cleve Clin J Med 2013;80:153-160.
12. Chen YC, Tang SC, Le H et al. Compare health development of rural areas in different districts of China: About social economy and inhabitant’shealth condition [in Chinese]. Chinese Health Economics 2006;25:37-38.
13. Centers for Disease Control and Prevention (CDC). Cancer screening: United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61:41-45.
14. Lee M, Chang HS, Park EC et al. Factors associated with participation of Korean women in cervical cancer screening examination by age group. Asian PacJ Cancer Prev2011;12:1457-1462.
15. Lin SJ. Factors influencing the uptake of screening services for breast and cervical cancer in Taiwan. J RSoc Promot Health 2008;128:327-334.
16. Ulijaszek SJ. Socio-economic status, forms of capital and obesity. J Gastrointest Cancer 2012;43: 3-7.
17. Kottke TE, Isham GJ. Measuring health care access and quality to improve health in populations. Prev Chronic Dis 2010;7:A73.
18. Feng X, Tang S, Bloom G et al. Cooperative medical schemes in contemporary rural China. Soc Sci Med 1995;41:1111-1118.
19. Yu B, Meng Q, Collins C et al. How does the New Cooperative Medical Scheme influence health service utilization?: A study in two provinces in rural China. BMC Health Serv Res 2010;10:116.
20. Qian D, Pong RW, Yin A et al. Determinants of health care demand in poor, rural China: The case of Gansu Province. Health Policy Plan 2009;24: 324-334.
21. Tang S, Meng Q, Chen L et al. Tackling the challenges to health equity in China. Lancet 2008; 372:1493-1501.
22. Saslow D, Runowicz CD, Solomon D et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
23. Gaffikin L, Blumenthal PD, Emerson M et al. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: A demonstration project. Lancet 2003; 361:814-820.
24. Denny L, Kuhn L, DeSouzaMetal.Screen-and-treat approaches for cervical cancer prevention in low-resource settings: A randomized controlled trial. JAMA 2005;294:2173-2181.
25. National Health and Family Planning Commission of the People’s Republic of China. The Technical Solution of Cervical Cancer Screening for Chinese Rural Women 2009 [in Chinese]. Available at http://www.nhfpc.gov.cn/fys/s3581/200909/53c0839f88f74bb0966d8c75d7304d2c.shtml. Accessed January 6, 2014.
26. Sankaranarayanan R, Nene BM, Dinshaw KA et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. IntJ Cancer 2005; 116:617-623.
27. Sankaranarayanan R, Esmy PO, Rajkumar R et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: A cluster-randomised trial. Lancet 2007;370: 398-406.
28. World Health Organization (WHO). WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention 2013. Available at http://www.who.int/reproductivehealth/topics/cancers/en/index.html. Accessed January 9, 2015.
29. Zhao FH, Lewkowitz AK, Chen F et al. Pooled analysis of a self-sampling HPVDNA test as a cervical cancer primary screening method. J Natl Cancer Inst 2012;104:178-188.
30. Zhao FH, Tiggelaar SM, Hu SY et al. A multi-center survey of age of sexual debut and sexual behavior in Chinese women: Suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol 2012;36:384-390.
31. Wu EQ, Liu B, Cui JF et al. Prevalence of type-specific human papillomavirus and pap results in Chinese women: A multi-center, population-based cross-sectional study. Cancer Causes Control 2013; 24:795-803.
32. Gu C, Chan CW, Twinn S. How sexual history and knowledge of cervical cancer and screening influence Chinese women’s screening behavior in mainland China. Cancer Nurs 2010;33:445-453.
33. Spadea T, Bellini S, Kunst A et al.The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: A review. Prev Med 2010;50:159-164.